European Respiratory Society
|Agreement labeling||EIFL European Respiratory Journal Agreement 2021-2023|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2021 – 12/31/2023|
|Consortia / Institution||EIFL|
|Country||Albania, Armenia, Azerbaijan, Belarus, Botswana, Congo, Ethiopia, Fiji, Georgia, Ghana, Ivory Coast, Kenya, Kosovo, Kyrgyzstan, Laos, Lesotho, North Macedonia, Malawi, Maldives, Moldova, Myanmar, Namibia, Nepal, Palestine, Senegal, Serbia, Sudan, Tanzania, Uganda, Ukraine, Uzbekistan, Zambia, Zimbabwe|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|No previous subscription spend for these countries|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY mandatory|
||Original research articles|
What is the approximate share of access related costs of the overall agreement?
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||No|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|